Compound 401 is a cell-permeable pyrimido-isoquinolinone compound that acts as a potent, reversible, and ATP-competitive inhibitor of DNA-PK (IC50 = 280 nM) with ~19-fold selectivity over mTOR (IC50 = 5.3 ?M).
More Information Supplier PageCompound 401 is a cell-permeable pyrimido-isoquinolinone compound that acts as a potent, reversible, and ATP-competitive inhibitor of DNA-PK (IC50 = 280 nM) with ~19-fold selectivity over mTOR (IC50 = 5.3 ?M).
More Information Supplier PageCompound 401 is a cell-permeable pyrimido-isoquinolinone compound that acts as a potent, reversible, and ATP-competitive inhibitor of DNA-PK (IC50 = 280 nM) with ~19-fold selectivity over mTOR (IC50 = 5.3 ?M).
More Information Supplier PageSL-251188, an oxazolidinone derivative, was characterized in baboons as a radioligand for the in vivo visualization of MAO-B using positron emission tomography (PET).
More Information Supplier PageCP-547632 is a novel, potent vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor
More Information Supplier PageCP-547632 is a novel, potent vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor
More Information Supplier PageCP-547632 is a novel, potent vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor
More Information Supplier PageCP-547632 is a novel, potent vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor
More Information Supplier PagePrucalopride is a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalising bowel movements.
More Information Supplier PagePrucalopride is a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalising bowel movements.
More Information Supplier Page
